| Code | 1463E | ||||||||||
| MA number | 09/0189/22-S | ||||||||||
| Product Form: | tbl mnd 96x680 mg/80 mg (blis.PVC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Bayer, spol. s r.o., Slovakia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 18.07.2022 |
| Validity: | 18.07.2027 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
PIL_Rennie s príchuťou pomaranča 680 mg_80 mg tbl mnd_07 2022.pdf
|
| SPC: |
SPC_Rennie s príchuťou pomaranča 680 mg_80 mg tbl mnd_07 2022.pdf
|
| Safety feature | Unknown |
| Data update: | 05.08.2022 |
